This study will look for novel biomarkers of kidney injury in patients receiving cisplatin in patients currently receiving cisplatin.~DNA will be collected both prospectively and retrospectively (from patients that have previously received cisplatin.
The purpose of this study is to identify novel biomarkers of kidney injury in patients receiving cisplatin.~This study will also collect DNA for future analysis.